Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SUE-HWA LIN and SONG-CHANG LIN.
SUE-HWA LIN
Connection Strength
4.848
SONG-CHANG LIN
  1. Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice. Cancers (Basel). 2024 Jul 21; 16(14).
    View in: PubMed
    Score: 0.977
  2. Endothelial-to-osteoblast transition in normal mouse bone development. iScience. 2023 Feb 17; 26(2):105994.
    View in: PubMed
    Score: 0.880
  3. Osteoblastic Factors in Prostate Cancer Bone Metastasis. Curr Osteoporos Rep. 2018 12; 16(6):642-647.
    View in: PubMed
    Score: 0.661
  4. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Dev Cell. 2017 06 05; 41(5):467-480.e3.
    View in: PubMed
    Score: 0.596
  5. Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization. Proc Natl Acad Sci U S A. 2024 Aug 13; 121(33):e2402903121.
    View in: PubMed
    Score: 0.245
  6. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. Oncogene. 2022 Feb; 41(6):757-769.
    View in: PubMed
    Score: 0.203
  7. Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone. Oncogene. 2021 Jul; 40(27):4592-4603.
    View in: PubMed
    Score: 0.197
  8. Bone secreted factors induce cellular quiescence in prostate cancer cells. Sci Rep. 2019 12 09; 9(1):18635.
    View in: PubMed
    Score: 0.177
  9. Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II. Cancer Res. 2018 05 15; 78(10):2490-2502.
    View in: PubMed
    Score: 0.157
  10. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGF?RIII-p38MAPK-pS249/T252RB Pathway. Cancer Res. 2018 06 01; 78(11):2911-2924.
    View in: PubMed
    Score: 0.157
  11. Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res. 2015 Nov 15; 75(22):4949-59.
    View in: PubMed
    Score: 0.133
  12. Angiomotin is a novel component of cadherin-11/?-catenin/p120 complex and is critical for cadherin-11-mediated cell migration. FASEB J. 2015 Mar; 29(3):1080-91.
    View in: PubMed
    Score: 0.125
  13. Cadherin-11 in renal cell carcinoma bone metastasis. PLoS One. 2014; 9(2):e89880.
    View in: PubMed
    Score: 0.119
  14. Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment. Clin Cancer Res. 2021 06 01; 27(11):3253-3264.
    View in: PubMed
    Score: 0.048
  15. Combinatorial effect of radium-223 and irreversible electroporation on prostate cancer bone metastasis in mice. Int J Hyperthermia. 2021; 38(1):650-662.
    View in: PubMed
    Score: 0.048
  16. Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo. Mol Cancer Ther. 2020 06; 19(6):1266-1278.
    View in: PubMed
    Score: 0.045
  17. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer. 2018 10; 16(5):325-327.
    View in: PubMed
    Score: 0.040
  18. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Neoplasia. 2018 01; 20(1):32-43.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.